Rchr
J-GLOBAL ID：201901006238349056   Update date: Oct. 28, 2024

Hiroki Kobayashi

コバヤシ ヒロキ | Hiroki Kobayashi
Affiliation and department：
Nihon University School of Medicine Division of Nephrology, Hypertension, and Endocrinology Department of Internal Medicine

About Nihon University School of Medicine Division of Nephrology, Hypertension, and Endocrinology Department of Internal Medicine


Other affiliations (1)：
Research field  (5)： Nephrology ,  Metabolism and endocrinology ,  Medical biochemistry ,  Physiology ,  Internal medicine - General
Research keywords  (12)： Diabetic kidney disease ,  disease modeling ,  Primary aldosteronism ,  Chronic kidney disease ,  Nephrology ,  Endocrinology ,  Diabetes ,  Hypertension ,  Renal replacement therapy ,  miRNA ,  Omics ,  Gerontology
Research theme for competitive and other funds  (35)：
  • 2024 - A challenge for innovation of chronic kidney disease treatment by trans-omics analysis
  • 2024 - Elucidation of myocardial fibrosis mechanisms focusing on a novel BMP antagonist molecule
  • 2024 - Elucidation of the fibrosis mechanism across multiple organs focusing on novel BMP antagonistic molecules
  • 2024 - Elucidation of the fibrotic mechanism spanning multiple organs through novel BMP antagonist
  • 2024 - Elucidation of the aldosterone secretion mechanism
Show all
Papers (92)：
  • Hiroki Kobayashi, Helen C. Looker, Katsuhito Ihara, Zaipul I, Md Dom, Eiichiro Satake, Sok Cin Tye, Kevin L. Duffin, Alessandro Doria, Robert G. Nelson, et al. Classification of predictors of rapid development of kidney failure and short-term changes in concentration of circulating proteins. Clinical Journal of the American Society of Nephrology. 2024
  • Naoki Fujiwara, Tatsuya Haze, Hiromichi Wakui, Kouichi Tamura, Mika Tsuiki, Kohei Kamemura, Daisuke Taura, Takamasa Ichijo, Yutaka Takahashi, Minemori Watanabe, et al. Differences in target organ damage between captopril challenge test-defined definitive-positive and borderline-range groups among patients with primary aldosteronism. Hypertension Research. 2024
  • Hiroki Kobayashi, Yoshihiro Nakamura, Masanori Abe, Toshifumi Nakamura, Yoichi Nozato, Shoichiro Izawa, Miki Kakutani, Takuyuki Katabami, Norio Wada, Katsutoshi Takahashi, et al. Prevalence of Unilateral Hyperaldosteronism in Primary Aldosteronism: Impact of a Novel Chemiluminescent Immunoassay for Measuring Plasma Aldosterone in Japan. Hypertension Research. 2024
  • Yoshihiro Nakamura, Hiroki Kobayashi, Noboru Fukuda, Sho Tanaka, Yusuke Murata, Yoshinari Hatanaka, Akira Haketa, Akiko Tsunemi, Lan Chen, Masanori Abe. Induced pluripotent stem cells derived renal tubular cells from a patient with pseudohypoparathyroidism and its response to parathyroid hormone stimulation. Molecular Biology Reports. 2024
  • Katsuhito Ihara, Eiichiro Satake, Parker C. Wilson, Bozena Krolewski, Hiroki Kobayashi, Zaipul Md Dom, Joseph Ricca, Jonathan Wilson, Jonathan M. Dreyfuss, Monika A. Niewczas, et al. Circulating proteins linked to apoptosis processes and fast development of end stage kidney disease in diabetes. JCI insight. 2024
ｍore...
Books (18)：
  • You Too Can Be a Great Doctor! Diabetic Kidney Disease (DKD)
    Japan medical journal 2024
  • Practical Guidebook to Endocrine Disease Diagnosis: Insights from Experts
    Japan medical journal 2024
  • Diabetes・Endocrinology Practice
    SOSHINSHA co. 2023
  • 腎臓栄養学
    2023
  • AKI on cardiac failure
    2023
ｍore...
Lectures and oral presentations  (134)：
  • Learning from the Proteomic Approach in Patients with Diabetes: From Biomarkers to Therapeutic Targets
    (The 61st European Renal Association (ERA), invited lecture, Stockholm 2024)
  • Identification of novel biomarkers and potential therapeutic targets in Diabetic Kidney Disease through blood proteome analysis.
    (The 12th Academy of Aging and Cardiovascular-Diabetes Research, invited lecture, Tokyo 2024)
  • Development of biomarkers that comprehensively capture the pathophysiology of diabetic kidney disease
    (The 59th Annual meeting of Society for Hypertesion Related Disease Model Research, symposium 2023)
  • Neuroblastoma suppressor of tumorigenicity 1 (NBL1) is a cause of kidney damage progression in diabetic kidney disease
    (The 59th Annual meeting of Society for Hypertesion Related Disease Model Research 2023)
  • Development of Biomarkers for Early Intervention in Diabetic Nephropathy and Their Application as Therapeutic Targets
    (The 34th Annual Meeting of Japan Diabetic Nephrology Study Group, symposium 2023)
ｍore...
Professional career (2)：
  • Ph.D. (Nihon University School of Medicine)
  • M.D. (Nihon University School of Medicine)
Work history (9)：
  • 2018 - 現在 Joslin Diabetes Center, Harvard Medical School Section on Genetics & Epidemiology, Research Division Research Fellow
  • 2018 - 現在 Nihon University School of Medicine Devision of Nephrology, Hypertension and Endocrinology Research Fellow
  • 2019 - 2021 Japan Society for the Promotion of Science Overseas Research Fellowships (Japanese government-sponsored)
  • 2018 - 2019 The Harvard Catalyst Education Program, Certificate in Applied Biostatistics
  • 2017 - 2018 Tokyo Metropolitan Hiroo Hospital Department of Diabetes and Endocrinology Attending physician
Show all
Committee career (6)：
  • 2024 - 現在 The Japanese Society of Hypertension councilor
  • 2024 - 現在 Japanese Society of Nephrology councilor
  • 2024 - 現在 Journal of Japanese Society for Dialysis Therapy councilor
  • 2023 - 現在 日本高血圧学会 高血圧学会基礎研究推進部会 委員
  • 2022 - Japanese Society of Renal Failure Complications Councilor
Show all
Awards (40)：
  • 2024 - Japan Society for the Promotion of Science Grant-in-Aid for Young Scientists
  • 2024 - The NOVARTIS Foundation for the Promotion of Science Research grant
  • 2024 - Yamaguchi Endocrine Research Foundation Research grant
  • 2023 - Nihon University School of Medicine Ozawa Research Grant
  • 2023 - Life Science Foundation of Japan Research grant
Show all
Association Membership(s) (13)：
Japanese Society of Renal Failure Complications ,  Japan Endocrine Pathology Society ,  Japan Hormonal Starcid Society ,  European Network for the Study of Adrenal Tumours (ENS@T) ,  American Society of Nephrology ,  The Endocrine Society ,  Japan Endocrine Society ,  The Japanese Society for Dialysis Therapy ,  The Japan Diabetes Society ,  Japanese Society of Nephrology ,  The Japanese Society of Internal Medicine ,  The Japanese Society of Hypertension ,  Japan Atherosclerosis Society
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page

TOP

BOTTOM